Bone Marrow Transplantation - Table of Contents alert Volume 50 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 50, Issue 4 (April 2015) In this issue Review Special Report Commentary Original Articles Letters to the Editor Also new AOP Review Top Engraftment syndrome: double-edged sword of hematopoietic cell transplants T R Spitzer Bone Marrow Transplant 2015 50: 469-475; advance online publication, January 12, 2015; 10.1038/bmt.2014.296 Abstract | Full Text Special Report Top Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants OPEN J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, R F Duarte, C Dufour, J H F Falkenburg, D Farge-Bancel, A Gennery, N Kröger, F Lanza, A Nagler, A Sureda and M Mohty for the European Society for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 2015 50: 476-482; advance online publication, February 2, 2015; 10.1038/bmt.2014.312 Abstract | Full Text Commentary Top Engraftment syndrome, the Emperor’s new clothes and the artist formerly known as prince R P Gale and H M Lazarus Bone Marrow Transplant 2015 50: 483-484; advance online publication, February 2, 2015; 10.1038/bmt.2014.317 Full Text Original Articles Top ACUTE LEUKEMIA Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT T Sauer, G Silling, C Groth, F Rosenow, U Krug, D Görlich, G Evers, J Albring, R Besoke, R M Mesters, C Müller-Tidow, T Kessler, T Büchner, W E Berdel and M Stelljes Bone Marrow Transplant 2015 50: 485-492; advance online publication, January 19, 2015; 10.1038/bmt.2014.300 Abstract | Full Text Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts G S Hobbs, A Hamdi, P D Hilden, J D Goldberg, M L Poon, C Ledesma, S M Devlin, G Rondon, E B Papadopoulos, A A Jakubowski, R J O'Reilly, R E Champlin, S Giralt, M-A Perales and P Kebriaei Bone Marrow Transplant 2015 50: 493-498; advance online publication, January 26, 2015; 10.1038/bmt.2014.302 Abstract | Full Text LYMPHOMA High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant L Castagna, R Crocchiolo, L Giordano, S Bramanti, C Carlo-Stella, B Sarina, A Chiti, E Mauro, S Gandolfi, E Todisco, M Balzarotti, A Anastasia, M Magagnoli, E Brusamolino and A Santoro Bone Marrow Transplant 2015 50: 499-504; advance online publication, January 26, 2015; 10.1038/bmt.2014.304 Abstract | Full Text PLASMA CELL DISORDERS Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial S Iacobelli, L C de Wreede, S Schönland, B Björkstrand, U Hegenbart, A Gruber, H Greinix, L Volin, F Narni, A M Carella, M Beksac, A Bosi, G Milone, P Corradini, K Friberg, A van Biezen, H Goldschmidt, T de Witte, C Morris, D Niederwieser, L Garderet, N Kröger and G Gahrton for the EBMT CMWP, Plasma Cell Disorders Subcommittee Bone Marrow Transplant 2015 50: 505-510; advance online publication, January 26, 2015; 10.1038/bmt.2014.310 Abstract | Full Text Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma L Giaccone, L Brunello, M Festuccia, M Gilestro, E Maffini, F Ferrando, E Talamo, R Passera, M Boccadoro, P Omedè and B Bruno Bone Marrow Transplant 2015 50: 511-516; advance online publication, February 9, 2015; 10.1038/bmt.2014.319 Abstract | Full Text INHERITED AND GENETIC DISORDERS Hematopoietic SCT in Iranian children 1991–2012 A A Hamidieh, M Behfar, A E S Babaki, A Jalali, A-S Hosseini, M Jahani, K Alimoghaddam and A Ghavamzadeh Bone Marrow Transplant 2015 50: 517-522; advance online publication, January 19, 2015; 10.1038/bmt.2014.299 Abstract | Full Text HEMATOPOIETIC CELL COLLECTION Pegfilgrastim vs filgrastim in PBSC mobilization for autologous hematopoietic SCT: a systematic review and meta-analysis M G Kim, N Han, E-K Lee and T Kim Bone Marrow Transplant 2015 50: 523-530; advance online publication, January 12, 2015; 10.1038/bmt.2014.297 Abstract | Full Text GRAFT SOURCE Cord blood collection and banking from a population with highly diverse geographic origins increase HLA diversity in the registry and do not lower the proportion of validated cord blood units: experience of the Marseille cord blood bank C Bordoni, J Magalon, C Gilbertas, M Gamerre, P Le Coz, M Berthomieu, C Chabannon, J Di Cristofaro and C Picard Bone Marrow Transplant 2015 50: 531-535; advance online publication, January 26, 2015; 10.1038/bmt.2014.314 Abstract | Full Text GRAFT MANIPULATION Major ABO incompatible BMT in children: determining what residual volume of donor red cells can safely be infused following red cell depletion K Patrick, W Lau, A Gassas, E McDougall, J Doyle, M Ali, J Krueger, S Courtney, C Armstrong, R M Egeler and T Schechter Bone Marrow Transplant 2015 50: 536-539; advance online publication, January 26, 2015; 10.1038/bmt.2014.309 Abstract | Full Text HISTOCOMPATIBILITY AND DONOR SELECTION ISSUES Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT V Kosmoliaptsis, M M Jöris, D H Mallon, A C Lankester, P A von dem Borne, J Kuball, M Bierings, J J Cornelissen, M E Groenendijk–Sijnke, B van der Holt, J A Bradley, M Oudshoorn, J J van Rood, C J Taylor and F H J Claas Bone Marrow Transplant 2015 50: 540-544; advance online publication, January 26, 2015; 10.1038/bmt.2014.305 Abstract | Full Text Efficiency of allogeneic hematopoietic SCT from HLA fully-matched non-sibling relatives: A new prospect of exploiting extended family search A A Hamidieh, M Ostadali Dehaghi, P Paragomi, S Navaei, A Jalali, G Ghazizadeh Eslami, M Behfar and A Ghavamzadeh Bone Marrow Transplant 2015 50: 545-552; advance online publication, January 26, 2015; 10.1038/bmt.2014.307 Abstract | Full Text TRANSPLANT TOXICITIES Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT K Takano, S Fuji, N Uchida, H Ogawa, K Ohashi, T Eto, H Sakamaki, Y Morishima, K Kato, R Suzuki and T Fukuda Bone Marrow Transplant 2015 50: 553-558; advance online publication, January 26, 2015; 10.1038/bmt.2014.315 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation H Nakasone, T Fukuda, J Kanda, T Mori, S Yano, T Kobayashi, K Miyamura, T Eto, H Kanamori, K Iwato, N Uchida, S Mori, T Nagamura-Inoue, T Ichinohe, Y Atsuta, T Teshima and M Murata on behalf of the GVHD working group of the Japan Society of Hematopoietic Cell Transplantation Bone Marrow Transplant 2015 50: 559-565; advance online publication, December 22, 2014; 10.1038/bmt.2014.293 Abstract | Full Text Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis A B M Lim, J Storek, A Beligaswatte, M Collins, M Tacey, T Williamson, K Mason, E Li, M A Chaudhry, J A Russell, A Daly, J Szer, I Lewis and D Ritchie Bone Marrow Transplant 2015 50: 566-572; advance online publication, February 2, 2015; 10.1038/bmt.2014.313 Abstract | Full Text INFECTIONS Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients C Kamber, S Zimmerli, F Suter-Riniker, B U Mueller, B M Taleghani, D Betticher, T Zander and T Pabst Bone Marrow Transplant 2015 50: 573-578; advance online publication, January 19, 2015; 10.1038/bmt.2014.290 Abstract | Full Text Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab I García-Cadenas, N Castillo, R Martino, P Barba, A Esquirol, S Novelli, G Orti, A Garrido, S Saavedra, C Moreno, M Granell, J Briones, S Brunet, F Navarro, I Ruiz, N Rabella, D Valcárcel and J Sierra Bone Marrow Transplant 2015 50: 579-584; advance online publication, January 12, 2015; 10.1038/bmt.2014.298 Abstract | Full Text Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia–lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group H Itonaga, Y Sawayama, J Taguchi, S Honda, H Taniguchi, J Makiyama, E Matsuo, S Sato, K Ando, D Imanishi, Y Imaizumi, S Yoshida, T Hata, Y Moriuchi, T Fukushima and Y Miyazaki Bone Marrow Transplant 2015 50: 585-591; advance online publication, January 26, 2015; 10.1038/bmt.2014.308 Abstract | Full Text QOL AND PATIENTS' CARE Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP A Lawitschka, M Faraci, I Yaniv, P Veys, P Bader, J Wachowiak, G Socie, M D Aljurf, M Arat, J J Boelens, R Duarte, A Tichelli and C Peters Bone Marrow Transplant 2015 50: 592-597; advance online publication, January 26, 2015; 10.1038/bmt.2014.306 Abstract | Full Text Letters to the Editor Top Inadvertent transmission of occult CML through allo-SCT M D de Brito, F Campilho, R Branca, C P Vaz and A Campos Bone Marrow Transplant 2015 50: 598; advance online publication, January 12, 2015; 10.1038/bmt.2014.294 Full Text Ponatinib given for advanced leukemia relapse after allo-SCT K Hirschbuehl, A Rank, T Pfeiffer, H R Slawik, G Schlimok, H J Kolb and Ch Schmid Bone Marrow Transplant 2015 50: 599-600; advance online publication, January 12, 2015; 10.1038/bmt.2014.301 Full Text A retrospective comparison of BU-fludarabine and BU–CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCT Y-q Sun, L-p Xu, X-h Zhang, D-h Liu, H Chen, Y Wang, C-h Yan, J-z Wang, F-r Wang, Y-y Zhang, K-y Liu and X-j Huang Bone Marrow Transplant 2015 50: 601-603; advance online publication, January 19, 2015; 10.1038/bmt.2014.303 Full Text Important impact of gingival and periodontal conditions on outcomes in SCT recipients V Allareddy, S R Venugopalan, S V K Eswaran, S Rampa, S Anamali, R P Nalliah, K Shin, V Allareddy and S Elangovan Bone Marrow Transplant 2015 50: 604-606; advance online publication, January 19, 2015; 10.1038/bmt.2014.311 Full Text I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases H Yamamoto, N Uchida, N Matsuno, A Kon, A Nishida, H Ota, T Ikebe, N Nakano, K Ishiwata, H Araoka, S Takagi, M Tsuji, Y Asano-Mori, G Yamamoto, K Izutsu, K Masuoka, A Wake, A Yoneyama, S Makino and S Taniguchi Bone Marrow Transplant 2015 50: 607-609; advance online publication, January 26, 2015; 10.1038/bmt.2014.316 Full Text Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis B Dhakal, A D'Souza, C Arce-Lara, M Pasquini, W Saber, F Falvo, J Esselman, K Zellner, T Fenske, P N Hari and M Hamadani Bone Marrow Transplant 2015 50: 610-612; advance online publication, January 26, 2015; 10.1038/bmt.2014.318 Full Text Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption C M Wilk, J C Fischer, G Schieren, J M Rox, R Haas, L C Rump, G Kobbe and T Schroeder Bone Marrow Transplant 2015 50: 613-614; advance online publication, January 26, 2015; 10.1038/bmt.2014.321 Full Text Constituting a public umbilical cord blood bank in South Africa J Mellet, M Alessandrini, H C Steel and M S Pepper Bone Marrow Transplant 2015 50: 615-616; advance online publication, January 26, 2015; 10.1038/bmt.2014.329 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.